Dyne Therapeutics (DYN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

DYN Dyne Therapeutics

Watchlist

35.240
+0.510+1.47%

Close Oct 18 16:00 ET

35.240
0.0000.00%

Post 16:56 ET

3.54BMarket Cap-9843P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Capricor Reports Positive Long-term Data for DMD Drug Deramiocel
Seeking AlphaOct 11 12:41 ET
Morgan Stanley Maintains Dyne Therapeutics(DYN.US) With Buy Rating, Maintains Target Price $52
Moomoo NewsOct 10 06:31 ET · Ratings
Analysts' Top Healthcare Picks: 10x Genomics (TXG), Dyne Therapeutics (DYN)
TipRanksOct 10 05:40 ET · Ratings
Dyne Therapeutics, Inc. (DYN): A Hot Stock to Buy Now
Yahoo FinanceOct 7 17:32 ET
Capricor Stock Rallies 20% on DMD Data Presentation Update
Seeking AlphaOct 4 13:33 ET
Avidity Gets FDA Partial Clinical Hold Lifted on DM1 Drug Candidate
Seeking AlphaOct 3 13:13 ET

Comments

Spinee

Jul 15 02:41

XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details

These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?
$XPeng (XPEV.US)$ stock rose 15.56%. Shares of Chinese stocks gained following an increase in China's June exports.
$QuantumScape (QS.US)$ stock jumped 64.34% after the company announced it entered into an agreement with Volkswagen $VOLKSWAGEN A G (VWAGY.US)$ 's battery company PowerC...

Trytosaveabit

May 20 12:31

$Dyne Therapeutics (DYN.US)$ Looking like a nice market response to the news/update

Trytosaveabit

May 20 05:42

News

$Dyne Therapeutics (DYN.US)$ Dyne Therapeutics Announces New Clinical Data From ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints
GlobeNewswire· 7 mins ago
- In Phase 1/2 ACHIEVE Trial, DYNE-101 Demonstrated Dose Dependent 27% Mean Splicing Correction Across All Patients in the 5.4 mg/kg Cohort at 3 Months -
- DYNE-101 Showed Improvement in Myotonia, Muscle Strength, ...